Chemomab Therapeutics Ltd. Quarterly Depreciation in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Chemomab Therapeutics Ltd. annual/quarterly Depreciation history and growth rate from Q1 2019 to Q1 2023.
  • Chemomab Therapeutics Ltd. Depreciation for the quarter ending March 31, 2023 was $16K, a 23.1% increase year-over-year.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2023 was $67K, a 15.5% increase from 2022.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2022 was $58K, a 70.6% increase from 2021.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2021 was $34K, a 41.7% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $16K +$3K +23.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $13K +$6K +85.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $7K +$2K +40% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $5K -$16K -76.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $21K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.